No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Sidoti Events, LLC's Virtual December Small-Cap Conference
Anika To Participate in December 2024 Investor Conferences
US Manufacturing Index Rises To 43, Highest Since 2020
Anika Therapeutics Navigates Geopolitical Risks Amid Global Conflicts
Anika Therapeutics | 10-Q: Q3 2024 Earnings Report
Anika Therapeutics, Inc. (ANIK) Q3 2024 Earnings Call Transcript Summary